---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-130468"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2023-12-29T23:59:59+00:00"
generated_at: "2026-06-07T05:59:44.494502+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Petros Pharma 2023 annual meeting: all director nominees elected, auditor ratified, say-on-pay passes

## Summary
- Elected directors John Shulman, Joshua Silverman, Bruce Bernstein, Gregory Bradley, Wayne Walker with over 88% of votes cast for each.
- Ratified EisnerAmper as independent auditor for FY 2023: 1,181,138 for, 91,884 against, 2,869 abstain.
- Advisory say-on-pay approved: 735,195 for, 30,435 against, 4,208 abstain; broker non-votes 506,053.
- All proposals passed at December 29, 2023 Annual Meeting; no other matters voted on.

## SEC filing metadata
- accession: 0001104659-23-130468
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2023-12-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465923130468/0001104659-23-130468-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465923130468/tm2333950d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-130468
- JSON: https://secwatch.observer/filing/0001104659-23-130468.json
- Plain text: https://secwatch.observer/filing/0001104659-23-130468.txt

## Key facts
- Shareholder Votes
  Petros Pharmaceuticals, Inc. shareholders approved Approval, on an advisory basis, of the compensation paid to the Company's named executive officers at the 2023-12-29 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-12-29
  source text: For Against Abstain Broker Non-Votes 735,195 30,435 4,208 506,053
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815903/000110465923130468/0001104659-23-130468-index.htm
- Shareholder Votes
  Petros Pharmaceuticals, Inc. shareholders approved Ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-12-29 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-12-29
  source text: For Against Abstain 1,181,138 91,884 2,869
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815903/000110465923130468/0001104659-23-130468-index.htm
- Shareholder Votes
  Petros Pharmaceuticals, Inc. shareholders approved Election of the five directors named in the Proxy Statement to the Board of Directors at the 2023-12-29 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-12-29
  source text: Nominee For Against Abstain Broker Non-Votes John D. Shulman 741,470 13,235 15,133 506,053
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815903/000110465923130468/0001104659-23-130468-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.